搜尋結果
US FDA approves Neurocrine Biosciences' movement disorder drug
Reuters· 6 小時前, opens new tab Ingrezza drug to treat movement disorders associated with Huntington's disease (HD), the company said on ...
Estrada, Yastrzemski hit back-to-back homers to lead Giants past Pirates, 3-2
Bastillepost· 4 日前A former teacher at New Hampshire’s youth detention center testified Monday that she reported ...
Sanctuary’s new humanoid robot learns faster and costs less | TechCrunch
TechCrunch· 7 日前Sanctuary AI often isn’t mentioned in the same breath as humanoid robotics firms like Boston Dynamics, Agility, Figure and ...